Oncology

This review set out to identify the initiatives needed to achieve better cancer-induced nausea and vomiting (CINV) control worldwide…

The complexity behind the treatment of breast cancer arises, in part, from the presence of biologically distinct subtypes…

March 11th 2020 marked the day that the World Health Organization (WHO) escalated the coronavirus SARS-CoV-2 (COVID-19) outbreak from a public health…

In accordance with ‘taking care’ of the cancer patient, the management of non-small cell lung cancer (NSCLC) is currently carried…

Lung cancer has a devastating global impact. Claiming over 2 million lives in 2018, it is the world’s leading cause of cancer-related morbidity…

This meeting took place on 28th September 2019, as part of the Ferring-organised Meet-The-Expert symposium at the European Society of Medical Oncology. Main topic is discussion of new treatment modalities in the management of high-risk, non-muscle invasive bladder cancer.

Cancer immunotherapy has been profiled as one of the major breakthroughs of the decade and will probably remain a paramount biomedical landmark in…

With a sustained number of new drugs or combination drugs entering standard of care this year, molecular testing should be…